10x Genomics SG&A Expenses 2018-2024 | TXG
10x Genomics sg&a expenses from 2018 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| 10x Genomics Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $343 |
| 2022 | $298 |
| 2021 | $258 |
| 2020 | $202 |
| 2019 | $131 |
| 2018 | $88 |
| 2017 | $47 |
| 10x Genomics Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $86 |
| 2023-12-31 | $86 |
| 2023-09-30 | $82 |
| 2023-06-30 | $92 |
| 2023-03-31 | $83 |
| 2022-12-31 | $79 |
| 2022-09-30 | $73 |
| 2022-06-30 | $79 |
| 2022-03-31 | $67 |
| 2021-12-31 | $70 |
| 2021-09-30 | $62 |
| 2021-06-30 | $69 |
| 2021-03-31 | $57 |
| 2020-12-31 | $56 |
| 2020-09-30 | $52 |
| 2020-06-30 | $44 |
| 2020-03-31 | $50 |
| 2019-12-31 | $39 |
| 2019-09-30 | $33 |
| 2019-06-30 | $33 |
| 2019-03-31 | $27 |
| 2018-12-31 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.369B | $0.619B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.992B | 19.76 |
| Hims & Hers Health (HIMS) | United States | $4.758B | 0.00 |
| Tempus AI (TEM) | United States | $4.172B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.020B | 0.00 |
| Axonics (AXNX) | United States | $3.455B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.168B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $3.167B | 0.00 |
| Azenta (AZTA) | United States | $2.962B | 166.54 |
| Enovis (ENOV) | United States | $2.469B | 18.30 |
| Privia Health (PRVA) | United States | $2.012B | 112.40 |
| Schrodinger (SDGR) | United States | $1.411B | 0.00 |
| Omnicell (OMCL) | United States | $1.252B | 43.29 |
| Phreesia (PHR) | United States | $1.163B | 0.00 |
| Standard BioTools (LAB) | United States | $0.667B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.632B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.630B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Talkspace (TALK) | United States | $0.365B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.357B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.301B | 0.00 |
| Pulmonx (LUNG) | United States | $0.238B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.197B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.180B | 0.00 |
| TruBridge (TBRG) | United States | $0.160B | 8.60 |
| American Well (AMWL) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.088B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.078B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.072B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.067B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.045B | 0.00 |
| Augmedix (AUGX) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.030B | 0.00 |
| CareCloud (CCLD) | United States | $0.030B | 0.00 |
| Movano (MOVE) | United States | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |